FDA Inspection
Zhejiang Excel Pharmaceutical Company, Ltd.Zhejiang Excel Pharmaceutical Company, Ltd. – FDA Inspection, Apr 12, 2024
Record Details
This FDA Inspection record concerns Zhejiang Excel Pharmaceutical Company, Ltd., with an inspection on April 12, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a870df77-720e-41a2-b2f7-0c5cc129b484
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1233323
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Zhejiang Excel Pharmaceutical Company, Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 1, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 31, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 28, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Excel Pharmaceutical Company, Ltd.
- FDA Inspection 963958 - 2016-04-01
- FDA Inspection 819131 - 2013-01-31
- FDA Inspection 565822 - 2009-01-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.